Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2017 December;58(6) > The Journal of Cardiovascular Surgery 2017 December;58(6):870-4

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  RECENT DEVELOPMENTS IN JUXTARENAL AND AORTO-ILIAC INTERVENTIONS 

The Journal of Cardiovascular Surgery 2017 December;58(6):870-4

DOI: 10.23736/S0021-9509.17.10069-8

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Endovascular treatment of mycotic aortic aneurysms: a paradigm shift

Karl SÖRELIUS , Kevin MANI, Martin BJÖRCK, Anders WANHAINEN

Section of Vascular Surgery, Department of Surgical Sciences, Uppsala, Sweden


PDF


Treatment of mycotic aortic aneurysms (MAAs) composes a particularly difficult challenge. Open repair has been considered the gold standard, despite lack of evidence supporting its superiority compared with the emerging alternative endovascular aortic repair (EVAR). This review discusses the pros and cons of EVAR for MAAs by dissecting the three largest publications on MAAs, and concludes that there has been a paradigm shift in treatment of MAAs for the benefit of EVAR.


KEY WORDS: Aortic aneurysm - Mycoses - Surgery - Endovascular procedures

top of page